Sign in

Mark Culhane

Director at Genasys
Board

About Mark Culhane

Mark Culhane, 65, joined the Genasys Inc. (GNSS) Board in July 2024 and is designated independent under Nasdaq rules. He is an experienced CFO and finance leader, currently Managing Partner at Culhane Advisory (since 2016), with prior CFO roles at Teradata (2017–2021), Lithium Technologies, DemandTec, iManage, and SciClone Pharmaceuticals; earlier in his career he held various positions at PwC. He holds a B.S. in Business Administration from the University of South Dakota and is recognized by the Board as an “audit committee financial expert.”

Past Roles

OrganizationRoleTenureCommittees/Impact
Teradata CorporationEVP & CFONov 2017 – Jun 2021Led public-company finance, reporting, controls
Lithium TechnologiesCFODec 2012 – Aug 2016Finance leadership at enterprise software firm
DemandTecEVP & CFOAug 2001 – May 2012Public-company finance, capital markets
iManageCFO1998 – 2001Finance and reporting
SciClone PharmaceuticalsCFO1992 – 1998Finance and public-company reporting
PricewaterhouseCoopersVarious roles1982 – 1992Accounting foundation; audit experience

External Roles

OrganizationRoleTenureCommittees/Impact
Culhane AdvisoryManaging Partner2016 – PresentStrategic finance advisory
UserZoomDirector, Audit Committee ChairApr 2017 – Apr 2022Audit oversight; private company context

Board Governance

  • Independence and structure: 6 of 7 GNSS directors are independent; Culhane is independent. The Board separates Chair (Osgood) and CEO (Danforth) roles.
  • Committee assignments: Culhane chairs both the Audit Committee (members: Culhane, Dodd, Malhotra, Schmeiser) and the Compensation Committee (members: Culhane, Dodd, Osgood).
  • Financial expertise: Board determined Culhane is an “audit committee financial expert.”
  • Attendance/engagement: In FY2024, the Board met 5 times; all directors serving during FY2024 attended at least 75% of Board and relevant committee meetings. Independent directors held at least two executive sessions in 2024.
  • Related parties: GNSS disclosed no related party transactions above SEC thresholds in FY2024.

Fixed Compensation

ComponentPolicy/DetailFY2024 – CulhaneNotes
Annual cash retainer$30,000 (prorated for partial year)$7,500No extra committee fees
Equity grant (RSUs)30,000 RSUs annually at annual meeting$45,400 grant-date fair value; initial grant of 20,000 RSUs (pro‑rated)ASC 718 fair value; 20,000 RSUs granted July 2024
Director compensation cap$500,000 annual cap (cash+equity grant-date fair value)In effect via 2025 PlanApplies to non-employee directors
  • Compensation committee oversees annual Board compensation and is chaired by Culhane.

Performance Compensation

  • Director equity is time-based RSUs; GNSS does not disclose director performance-based metrics. However, as Compensation Committee Chair, Culhane oversees executive incentive design. FY2025 executive incentive plan metrics: total product bookings, net revenues, operating income, and operating cash flow; target bonus percentages (CEO 75%, CFO 50%) and 50%/100%/200% payout levels based on performance.
Executive Incentive Metrics (FY2025)Metric Type
Total Product BookingsCorporate financial metric
Net RevenuesCorporate financial metric
Operating IncomeProfitability metric
Operating Cash FlowCash generation metric

Other Directorships & Interlocks

  • Current public company directorships (besides GNSS): None disclosed for Culhane.
  • Compensation committee interlocks: GNSS disclosed no interlocks or insider participation for FY2024; Culhane served on the Compensation Committee in FY2024 and was not an officer.

Expertise & Qualifications

  • Core qualifications: Public-company CFO experience; audit and financial reporting expertise; Board-designated audit committee financial expert.
  • Education: B.S., Business Administration, University of South Dakota.

Equity Ownership

HolderShares Beneficially OwnedPercent of ClassIncludes RSUs/Options Exercisable/Settleable within 60 Days
Mark Culhane70,000<1%20,000 shares via options/RSUs within 60 days of Jan 28, 2025
  • Hedging policy: GNSS has not adopted a policy restricting hedging transactions by directors or employees.
  • Clawbacks: GNSS adopted a clawback policy in line with Nasdaq rules; 2025 Equity Plan subjects awards to any company clawback policy.

Governance Assessment

  • Strengths

    • Dual committee leadership: Culhane chairs both Audit and Compensation, bringing deep finance rigor to oversight; Board recognizes him as an audit committee financial expert.
    • Independence and attendance: Independent status; Board and committees met regularly, with directors meeting attendance thresholds; independent director executive sessions held.
    • Equity alignment: Director compensation is equity-heavy (RSUs) alongside modest cash retainer; no committee fees reduce pay inflation risk.
    • Clean related-party profile: No related-party transactions disclosed for FY2024.
    • Market feedback: Prior say-on-pay support was strong at 94.3%, indicating investor acceptance of compensation framework overseen by the Compensation Committee.
  • Red Flags / Watch Items

    • Concentration of oversight: The same individual chairs both Audit and Compensation (Culhane), which can consolidate oversight influence and increase workload; boards typically separate these roles to diversify control.
    • Hedging policy gap: GNSS has not adopted a hedging policy for directors/executives, which can weaken ownership alignment signals.
    • Activism context: Recent cooperation agreement with Nicoya added a new director (Malhotra) and expanded the Board; while not directly implicating Culhane, ongoing activist dynamics warrant monitoring of committee independence and priorities.

Overall: Culhane’s credentials and independent status support board effectiveness in core oversight areas. Key investor concerns to monitor are the combination of Audit and Compensation chair roles and the absence of a formal hedging prohibition, which can affect confidence in risk oversight and alignment.